Your browser doesn't support javascript.
loading
Purification of High Yield Extracellular Vesicle Preparations Away from Virus.
DeMarino, Catherine; Barclay, Robert A; Pleet, Michelle L; Pinto, Daniel O; Branscome, Heather; Paul, Siddhartha; Lepene, Benjamin; El-Hage, Nazira; Kashanchi, Fatah.
Afiliación
  • DeMarino C; Laboratory of Molecular Virology, School of Systems Biology, George Mason University.
  • Barclay RA; Laboratory of Molecular Virology, School of Systems Biology, George Mason University.
  • Pleet ML; Laboratory of Molecular Virology, School of Systems Biology, George Mason University.
  • Pinto DO; Laboratory of Molecular Virology, School of Systems Biology, George Mason University.
  • Branscome H; Laboratory of Molecular Virology, School of Systems Biology, George Mason University; American Type Culture Collection (ATCC).
  • Paul S; ATCC Cell Systems.
  • Lepene B; Ceres Nanosciences, Inc.
  • El-Hage N; Department of Immunology and Nano-medicine, Herbert Wertheim College of Medicine, Florida International University.
  • Kashanchi F; Laboratory of Molecular Virology, School of Systems Biology, George Mason University; fkashanc@gmu.edu.
J Vis Exp ; (151)2019 09 12.
Article en En | MEDLINE | ID: mdl-31566605
ABSTRACT
One of the major hurdles in the field of extracellular vesicle (EV) research today is the ability to achieve purified EV preparations in a viral infection setting. The presented method is meant to isolate EVs away from virions (i.e., HIV-1), allowing for a higher efficiency and yield compared to conventional ultracentrifugation methods. Our protocol contains three

steps:

EV precipitation, density gradient separation, and particle capture. Downstream assays (i.e., Western blot, and PCR) can be run directly following particle capture. This method is advantageous over other isolation methods (i.e., ultracentrifugation) as it allows for the use of minimal starting volumes. Furthermore, it is more user friendly than alternative EV isolation methods requiring multiple ultracentrifugation steps. However, the presented method is limited in its scope of functional EV assays as it is difficult to elute intact EVs from our particles. Furthermore, this method is tailored towards a strictly research-based setting and would not be commercially viable.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virión / Vesículas Extracelulares Límite: Humans Idioma: En Revista: J Vis Exp Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virión / Vesículas Extracelulares Límite: Humans Idioma: En Revista: J Vis Exp Año: 2019 Tipo del documento: Article